Article Text

Download PDFPDF
Technology (including: robots for production, Incompatibilities, drug production and analytics, CRS)
The performance improvements of the 3rd generation robot for the automated compounding of oncology drugs
  1. C. Bufarini,
  2. A. Marinozzi,
  3. S. Guglielmi,
  4. D. Paolucci
  1. 1AO Ospedali Riuniti, Farmacia, Ancona, Italy
  2. 2Loccioni, Humancare, Moie (An), Italy


Background The collaboration established in 2007 between the Oncology Pharmacy of the University Hospital of Ancona and the Loccioni Group was aimed at implementing, validating and integrating the robotised system for the chemotherapic drugs compounding in the day-to-day pharmacy activity. Currently the Oncology Pharmacy is almost totally automated (95%) and Loccioni has its clinical site for the continuous engineering. During this 4-year period, the constant implementation gave rise to three generations of robot with the final version ApotecaChemo released late in 2009. The authors had the chance to experience all three generations and to validate the tough work done to increase efficiency, ergonomics and user-friendliness.

Purpose The objective of this work is to analyse the performance of the third generation robot and to compare it with the previous ones.</p>

Materials and methods Data were obtained from the robot database. An other advantage of automation is related to the data mining. Every step is measured and traced, providing a huge amount of information helpful for both performance statistics and process re-organisation. In this case, The authors compared production rate and the preparation time of specific drugs in standard protocols along the years.</p>

Results The average preparation time of a fluorouracil bag of a CMF protocol halved from 303 to 156 s with the 3<sup>rd</sup> generation robot. Similar trend is recorded for a methotrexate bag (CMF) and an epirubicin bag (FEC), whose preparation time passed from 276 to 127 s and from 565 to 253 s respectively. The improvement is even more significant for other drugs like gemcitabine, which is about 80%.

Conclusions This technology has developed rapidly reaching high production rate. Nowadays, ApotecaChemo performances are comparable to those of the manual activity, with the added values of a quali-quantitative certification of each preparation compounded.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.